Injectable Semaglutide
Semaglutide (the active ingredient in Ozempic® and Wegovy®) works as an agonist on only the GLP-1 (Glucagon-like Peptide-1) receptor, leading to increased insulin release, reduced glucagon secretion, slowed gastric emptying, and increased feelings of fullness, and it is used to improve blood sugar control and, in higher doses, for weight management.
Details
*Activation of the GLP-1 receptor leads to several beneficial effects with both semaglutide and tirzepatide
- Increased insulin release
- Reduced glucagon secretion
- Slowed gastric emptying and increased feelings of fullness
- Decreased hunger through satiety pathways
- Up-modulates fat utilization
- Reduced ghrelin levels in the stomach/gut
Play Video about Town Country Compounding Pharmacy New Jersey New York NYC GLP-1 Semaglutide Tirzepatide Prescription rx medication weight loss
High Quality, Fast Turnaround GLP-1 Injections During the FDA Shortage
Play Video about Town Country Compounding Pharmacy New Jersey New York NYC GLP-1 Semaglutide Tirzepatide Prescription rx medication weight loss
Compounded Semaglutide & Tirzepatide GLP 1s: How We Help Patients – Patient Video Instructions
